Validation of the Modified Frailty Phenotype Measure in Older Mexican Americans.
Age Distribution
Age Factors
Aged
Aged, 80 and over
Cross-Sectional Studies
Female
Follow-Up Studies
Forecasting
Frailty
/ diagnosis
Humans
Incidence
Male
Mexican Americans
/ statistics & numerical data
Motor Activity
/ physiology
Phenotype
Reproducibility of Results
Retrospective Studies
Sex Distribution
Sex Factors
United States
/ epidemiology
Mexican Americans
frail older adults
minority health
Journal
Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
15
05
2019
revised:
28
06
2019
accepted:
10
07
2019
pubmed:
16
8
2019
medline:
22
5
2020
entrez:
16
8
2019
Statut:
ppublish
Résumé
Develop and validate a modified frailty phenotype measure for older Mexican Americans participating in the Hispanic Established Populations for the Epidemiological Study of the Elderly (H-EPESE) and related studies. Expert-based panel evaluation of content validity, cross-sectional analysis of construct validity, and longitudinal analysis of criterion validity for a modified version of the frailty phenotype measure. Five southwestern states. A total of 1833 community-dwelling Mexican Americans aged 67 years or older. Frailty was assessed using the frailty phenotype measure (weight loss, weakness, exhaustion, slowness, and low physical activity) and a modified frailty phenotype measure (replacing "low physical activity" with "limitations in walking half a mile"). Each individual was classified as non-frail, pre-frail, or frail based on both frailty measures (original vs modified). Expert panel consensus was used to examine content validity. Spearman correlation, κ, weighted κ, and bootstrapping κ examined construct validity (n = 1833). Generalized linear mixed models, odds ratios, Cox proportional regression models, hazard ratios, and C statistics were used to analyze criterion validity (n = 1446) across four outcomes: hospitalization, physician visits, disability, and mortality from wave 3 (1998-99) through wave 8 (2012-13). The original and modified frailty phenotype measures had a strong correlation (r = .89; P < .000) and agreement (κ = .84; 95% confidence interval [CI] = .81-.86; weighted κ = .86; 95% CI = .84-.88; bootstrap κ = .84; 95% CI = .81-.86; bootstrap-weighted κ = .86; 95% CI = .84-.88 with 1000 bootstrapping samples). Four outcome models showed similar risk predictions for both frailty measures, with the exception of physician visits for frail participants. "Limitations in walking half a mile" can be used as a substitute criterion for "low physical activity" in assessing frailty. The modified frailty phenotype measure was comparable with the original frailty phenotype measure in H-EPESE participants over time. Our results indicate the modified frailty phenotype is a useful longitudinally frailty measure for community-dwelling older Mexican Americans. J Am Geriatr Soc 67:2393-2397, 2019.
Identifiants
pubmed: 31414494
doi: 10.1111/jgs.16104
pmc: PMC6861608
mid: NIHMS1045311
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2393-2397Subventions
Organisme : NIA NIH HHS
ID : P30 AG059301
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG010939
Pays : United States
Organisme : NIMHD NIH HHS
ID : R01 MD010355
Pays : United States
Organisme : NIA NIH HHS
ID : R01-AG10939
Pays : United States
Informations de copyright
© 2019 The American Geriatrics Society.
Références
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):744-51
pubmed: 17634322
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
J Gerontol A Biol Sci Med Sci. 2000 Dec;55(12):M706-8
pubmed: 11129391
Clin Geriatr Med. 2011 Feb;27(1):17-26
pubmed: 21093719
Stat Med. 2004 Jul 15;23(13):2109-23
pubmed: 15211606
Ann Epidemiol. 2018 Jun;28(6):362-367.e3
pubmed: 29703521
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
Circulation. 2007 Feb 20;115(7):928-35
pubmed: 17309939
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1427-34
pubmed: 26297656
BMC Geriatr. 2010 Aug 24;10:57
pubmed: 20731877
J Clin Epidemiol. 1993 Feb;46(2):153-62
pubmed: 8437031
Intensive Care Med. 2017 Aug;43(8):1105-1122
pubmed: 28676896
Am J Public Health. 2009 Apr;99(4):673-9
pubmed: 19197079
J Nutr Health Aging. 2012 Feb;16(2):142-7
pubmed: 22323349
Rev Bras Enferm. 2016 Jul-Aug;69(4):691-6
pubmed: 27508474
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43
pubmed: 17634321
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Ageing Res Rev. 2015 May;21:78-94
pubmed: 25846451
J Gerontol A Biol Sci Med Sci. 2002 May;57(5):M283-8
pubmed: 11983721
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M134-5
pubmed: 11253153
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Am Geriatr Soc. 2007 Aug;55(8):1216-23
pubmed: 17661960
J Am Geriatr Soc. 2005 Jun;53(6):927-34
pubmed: 15935013
J Nerv Ment Dis. 1987 Dec;175(12):731-7
pubmed: 3500273
Age Ageing. 2005 Sep;34(5):432-4
pubmed: 16107450